These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 19478256)

  • 1. Magnetic resonance imaging findings in human African trypanosomiasis: a four-year follow-up study in a patient and review of the literature.
    Kager PA; Schipper HG; Stam J; Majoie CB
    Am J Trop Med Hyg; 2009 Jun; 80(6):947-52. PubMed ID: 19478256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
    Checkley AM; Pepin J; Gibson WC; Taylor MN; Jäger HR; Mabey DC
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):523-6. PubMed ID: 17270227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychiatric presentation of human African trypanosomiasis: overview of diagnostic pitfalls, interest of difluoromethylornithine treatment and contribution of magnetic resonance imaging].
    Bédat-Millet AL; Charpentier S; Monge-Strauss MF; Woimant F
    Rev Neurol (Paris); 2000 May; 156(5):505-9. PubMed ID: 10844370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis.
    Jennings FW; Gichuki CW; Kennedy PG; Rodgers J; Hunter CA; Murray M; Burke JM
    Neuropathol Appl Neurobiol; 1997 Jun; 23(3):225-34. PubMed ID: 9223132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings.
    Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T
    Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eflornithine for the treatment of human African trypanosomiasis.
    Burri C; Brun R
    Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual MRI Findings in African
    Boukobza M; Lariven S; Houzé S; Laissy JP
    Am J Trop Med Hyg; 2020 Jan; 102(1):5-6. PubMed ID: 31971136
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).
    Schmid C; Richer M; Bilenge CM; Josenando T; Chappuis F; Manthelot CR; Nangouma A; Doua F; Asumu PN; Simarro PP; Burri C
    J Infect Dis; 2005 Jun; 191(11):1922-31. PubMed ID: 15871127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders.
    Keita M; Bouteille B; Enanga B; Vallat JM; Dumas M
    Exp Parasitol; 1997 Feb; 85(2):183-92. PubMed ID: 9030668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis).
    Blum JA; Burri C; Hatz C; Kazumba L; Mangoni P; Zellweger MJ
    Trop Med Int Health; 2007 Dec; 12(12):1422-32. PubMed ID: 18076548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical reasoning and decision making in practice. A depressive foreign woman with symptoms of malaise].
    Hart W; Slee PH; Schipper HG; Koopmans RP; Kager PA
    Ned Tijdschr Geneeskd; 2004 Apr; 148(16):771-6. PubMed ID: 15129565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal African trypanosomiasis in a traveler: MRI and neuropathology.
    Braakman HM; van de Molengraft FJ; Hubert WW; Boerman DH
    Neurology; 2006 Apr; 66(7):1094-6. PubMed ID: 16606924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease.
    Truc P; Lando A; Penchenier L; Vatunga G; Josenando T
    Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human African trypanosomiasis caused by Trypanosoma brucei gambiense: The first case report in China.
    Chen N; Jin K; Xu J; Zhang J; Weng Y
    Int J Infect Dis; 2019 Feb; 79():34-36. PubMed ID: 30423460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kenyan purple tea anthocyanins and coenzyme-Q10 ameliorate post treatment reactive encephalopathy associated with cerebral human African trypanosomiasis in murine model.
    Rashid K; Wachira FN; Nyariki JN; Isaac AO
    Parasitol Int; 2014 Apr; 63(2):417-26. PubMed ID: 24440762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electroencephalographic study of trypanosomes in meningoencephalitic stage of human African trypanosomiasis from Trypanosoma brucei gambiense before and after treatment with DL-alphadifluoromethyl- ornithine hydrochloride monohydrate (DFMO)].
    Hamon JF; Camara P
    Bull Soc Pathol Exot; 1992; 85(5):378-84. PubMed ID: 1292798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
    Miezan TW; Dje NN; Doua F; Boa F
    Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.